Skip to content

US FDA issues 4 observations for Biocon Biologics#39; insulin facility

The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL#39;s customer late last year

Read More

​ The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL#39;s customer late last year The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL#39;s customer late last year  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish